JAK2 and breast carcinoma: In conclusion, our study indicates that JAKi enhance metastasis in experimental models of breast cancer by inhibiting NK-cell functions (Fig. 8c), and that JAK2 has an essential role in controlling NK-cell-mediated tumour immunosurveillance.